163 related articles for article (PubMed ID: 12220732)
1. Somatostatin inhibits glucagon-like peptide-1-induced insulin secretion and proliferation of RINm5F insulinoma cells.
Stark A; Mentlein R
Regul Pept; 2002 Oct; 108(2-3):97-102. PubMed ID: 12220732
[TBL] [Abstract][Full Text] [Related]
2. Interaction of glucagon-like peptide-1(7-36)amide and somatostatin-14 in RINm5F cells and in the perfused rat pancreas.
Göke R; Fehmann HC; Richter G; Trautmann M; Göke B
Pancreas; 1989; 4(6):668-73. PubMed ID: 2573056
[TBL] [Abstract][Full Text] [Related]
3. Glucagon-like peptide-1 improves insulin and proinsulin binding on RINm5F cells and human monocytes.
Ebinger M; Jehle DR; Fussgaenger RD; Fehmann HC; Jehle PM
Am J Physiol Endocrinol Metab; 2000 Jul; 279(1):E88-94. PubMed ID: 10893327
[TBL] [Abstract][Full Text] [Related]
4. Effects of glucagon-like peptide-1 (GLP-1) in RINm5F insulinoma cells. Stimulation of insulin secretion, insulin content, and insulin receptor binding.
Jehle PM; Jehle D; Fussgänger RD; Adler G
Exp Clin Endocrinol Diabetes; 1995; 103 Suppl 2():31-6. PubMed ID: 8839251
[TBL] [Abstract][Full Text] [Related]
5. Ligand-induced regulation of glucagon-like peptide-I receptor function and expression in insulin-secreting beta cells.
Fehmann HC; Jiang J; Pitt D; Schweinfurth J; Göke B
Pancreas; 1996 Oct; 13(3):273-82. PubMed ID: 8884849
[TBL] [Abstract][Full Text] [Related]
6. Synergistic effect of dimethyl sulfoxide on glucagon-like peptide 1 (GLP-1)-stimulated insulin secretion and gene transcription in INS-1 cells: characterization and implications.
Kemp DM; Habener JF
Biochem Pharmacol; 2002 Aug; 64(4):689-97. PubMed ID: 12167488
[TBL] [Abstract][Full Text] [Related]
7. Functional receptors for the insulinotropic hormone glucagon-like peptide-I(7-37) on a somatostatin secreting cell line.
Fehmann HC; Habener JF
FEBS Lett; 1991 Feb; 279(2):335-40. PubMed ID: 1672112
[TBL] [Abstract][Full Text] [Related]
8. Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells.
Göke R; Fehmann HC; Linn T; Schmidt H; Krause M; Eng J; Göke B
J Biol Chem; 1993 Sep; 268(26):19650-5. PubMed ID: 8396143
[TBL] [Abstract][Full Text] [Related]
9. Stimulatory effects of glucagon-like peptides on human insulinoma cells and insulin-releasing clonal RINm5F cells.
Flatt PR; Shiber O; Hampton SM; Marks V
Diabetes Res; 1990 Feb; 13(2):55-9. PubMed ID: 1965428
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of glucose stimulated insulin secretion by neuropeptide Y is mediated via the Y1 receptor and inhibition of adenylyl cyclase in RIN 5AH rat insulinoma cells.
Morgan DG; Kulkarni RN; Hurley JD; Wang ZL; Wang RM; Ghatei MA; Karlsen AE; Bloom SR; Smith DM
Diabetologia; 1998 Dec; 41(12):1482-91. PubMed ID: 9867216
[TBL] [Abstract][Full Text] [Related]
11. Glucagon-like peptide 1 stimulates insulin gene promoter activity by protein kinase A-independent activation of the rat insulin I gene cAMP response element.
Skoglund G; Hussain MA; Holz GG
Diabetes; 2000 Jul; 49(7):1156-64. PubMed ID: 10909973
[TBL] [Abstract][Full Text] [Related]
12. Glucagon-like peptide-1 inhibits apoptosis of insulin-secreting cells via a cyclic 5'-adenosine monophosphate-dependent protein kinase A- and a phosphatidylinositol 3-kinase-dependent pathway.
Hui H; Nourparvar A; Zhao X; Perfetti R
Endocrinology; 2003 Apr; 144(4):1444-55. PubMed ID: 12639928
[TBL] [Abstract][Full Text] [Related]
13. Glucagon-like peptide-1 affects gene transcription and messenger ribonucleic acid stability of components of the insulin secretory system in RIN 1046-38 cells.
Wang Y; Egan JM; Raygada M; Nadiv O; Roth J; Montrose-Rafizadeh C
Endocrinology; 1995 Nov; 136(11):4910-7. PubMed ID: 7588224
[TBL] [Abstract][Full Text] [Related]
14. Mutations to the third cytoplasmic domain of the glucagon-like peptide 1 (GLP-1) receptor can functionally uncouple GLP-1-stimulated insulin secretion in HIT-T15 cells.
Salapatek AM; MacDonald PE; Gaisano HY; Wheeler MB
Mol Endocrinol; 1999 Aug; 13(8):1305-17. PubMed ID: 10446905
[TBL] [Abstract][Full Text] [Related]
15. Regulation of insulin and glucagon secretion from rat pancreatic islets in vitro by somatostatin analogues.
Ludvigsen E; Stridsberg M; Taylor JE; Culler MD; Oberg K; Janson ET; Sandler S
Regul Pept; 2007 Jan; 138(1):1-9. PubMed ID: 16935361
[TBL] [Abstract][Full Text] [Related]
16. Incretin hormones regulate glucose-dependent insulin secretion in RIN 1046-38 cells: mechanisms of action.
Montrose-Rafizadeh C; Egan JM; Roth J
Endocrinology; 1994 Aug; 135(2):589-94. PubMed ID: 8033807
[TBL] [Abstract][Full Text] [Related]
17. Neuropeptide Y expression and regulation in a differentiated rat insulin-secreting cell line.
Waeber G; Thompson N; Waeber B; Brunner HR; Nicod P; Grouzmann E
Endocrinology; 1993 Sep; 133(3):1061-7. PubMed ID: 8396008
[TBL] [Abstract][Full Text] [Related]
18. Glucagon-like peptide-1 induces a cAMP-dependent increase of [Na+]i associated with insulin secretion in pancreatic beta-cells.
Miura Y; Matsui H
Am J Physiol Endocrinol Metab; 2003 Nov; 285(5):E1001-9. PubMed ID: 14534075
[TBL] [Abstract][Full Text] [Related]
19. Impaired cyclic AMP response to stimuli in glucose-desensitized rat pancreatic islets.
Laychock SG
Mol Cell Endocrinol; 1995 Aug; 113(1):19-28. PubMed ID: 8674810
[TBL] [Abstract][Full Text] [Related]
20. Interaction of glucagon-like peptide-I (GLP-I) and galanin in insulin (beta TC-1)- and somatostatin (RIN T3)-secreting cells and evidence that both peptides have no receptors on glucagon (INR1G9)-secreting cells.
Fehmann HC; Janssen M; Göke B
Acta Diabetol; 1995 Oct; 32(3):176-81. PubMed ID: 8590787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
